The Pathogenesis of Aspergillus Keratitis

曲霉菌性角膜炎的发病机制

基本信息

  • 批准号:
    8326714
  • 负责人:
  • 金额:
    $ 5.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-01 至 2013-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The incidence of human fungal infections has steadily increased over the past few decades. Though associated with an increased immunosuppressed population size, not all fungal infections necessitate an immunocompromised hosts. This is especially true for filamentous fungal infections of the cornea (i.e keratitis), in which the majority of patients are fully immunocompetent. Indeed, in such cases the etiology of corneal pathology is due to an excessive inflammatory response to the invading organism, not the infection itself. During Aspergillus keratitis, the inflammation can be so severe that 42-60% of infections end with corneal transplantation. Before such bleak clinical outcomes improve, we must invest in research to better understand the mediators of host-fungai interactions. This proposal will utilize a murine corneal infection model (i.e Aspergillus keratitis) to address gaps in our current understanding of in vivo host-mycelia interactions. Using this model, we will address the hypothesis that specific pathogen recognition receptors on resident macrophages mediate neutrophil recruitment into the cornea during Aspergillus keratitis (AIM 1). In AIM 2 we will address the hypothesis that similar receptors on infiltrating neutrophils mediate A. fumigatus hyphal killing. Lastly, in AIM 3 we will address the hypothesis that the fungal secondary metabolite, gliotoxin, mediates fungal survival and enhanced corneal pathology during Aspergillus keratitis through inhibition of reactive oxygen species formation by infiltrating neutrophils. The studies proposed herein will greatly expand our understanding of host-mycelial interactions in the cornea, while identifying anti-inflammatory and anti-fungal targets for therapeutic intervention during Aspergillus keratitis. Lay Language: The goal of this proposal is to identify potential anti-inflammatory and anti-fungal therapeutic targets during Aspergillus fumigatus infection in the cornea. We propose to do this by using mouse models of A. fumigatus corneal infection to study the innate immune receptors required for recognition and killing of this fungus, as well as the mechanism by which A.fumigatus evades fungal killing during corneal infection.
描述(由申请人提供):在过去的几十年里,人类真菌感染的发病率稳步上升。虽然与免疫抑制群体规模增加有关,但并非所有真菌感染都需要免疫功能低下的宿主。对于丝状真菌感染的角膜(即角膜炎)尤其如此,其中大多数患者具有完全的免疫能力。事实上,在这种情况下,角膜病理的病因是由于对入侵生物体的过度炎症反应,而不是感染本身。在曲霉菌性角膜炎期间,炎症可能非常严重,42-60%的感染以角膜移植结束。在这种惨淡的临床结果得到改善之前,我们必须投资于研究,以更好地了解宿主-真菌相互作用的介质。该建议将利用小鼠角膜感染模型(即曲霉菌角膜炎)来解决我们目前对体内宿主-菌丝相互作用的理解空白。利用该模型,我们将探讨在曲霉菌性角膜炎(AIM 1)期间,巨噬细胞上的特异性病原体识别受体介导中性粒细胞向角膜募集的假设。在AIM 2中,我们将讨论浸润中性粒细胞上的类似受体介导烟曲霉菌丝杀死的假设。最后,在AIM 3中,我们将讨论真菌次生代谢物胶质毒素通过抑制浸润中性粒细胞形成活性氧来介导曲霉菌角膜炎期间真菌存活和增强角膜病理的假设。本文提出的研究将极大地扩展我们对角膜中宿主-菌丝相互作用的理解,同时确定曲霉菌性角膜炎治疗干预的抗炎和抗真菌靶点。本提案的目的是在角膜烟曲霉感染期间确定潜在的抗炎和抗真菌治疗靶点。我们拟利用烟曲霉角膜感染小鼠模型,研究该真菌识别和杀伤所需的先天免疫受体,以及烟曲霉在角膜感染过程中逃避真菌杀伤的机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sixto Manuel Leal其他文献

Sixto Manuel Leal的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sixto Manuel Leal', 18)}}的其他基金

The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal Immunity
SARS-CoV-2 免疫失调对抗真菌免疫的影响
  • 批准号:
    10658355
  • 财政年份:
    2023
  • 资助金额:
    $ 5.55万
  • 项目类别:
Facility Management, Maintenance and Operations Core
设施管理、维护和运营核心
  • 批准号:
    10792751
  • 财政年份:
    2023
  • 资助金额:
    $ 5.55万
  • 项目类别:
Enhancing SEBLAB Research Productivity, Operations and Core Laboratory Support
提高 SEBLAB 研究生产力、运营和核心实验室支持
  • 批准号:
    10792750
  • 财政年份:
    2023
  • 资助金额:
    $ 5.55万
  • 项目类别:
Biocontainment Research Support Service(s) Core-Optional
生物防护研究支持服务核心-可选
  • 批准号:
    10792753
  • 财政年份:
    2023
  • 资助金额:
    $ 5.55万
  • 项目类别:
BSL-3 Practices Core
BSL-3 实践核心
  • 批准号:
    10792752
  • 财政年份:
    2023
  • 资助金额:
    $ 5.55万
  • 项目类别:
The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal Immunity
SARS-CoV-2 免疫失调对抗真菌免疫的影响
  • 批准号:
    10668549
  • 财政年份:
    2022
  • 资助金额:
    $ 5.55万
  • 项目类别:
Augmenting Scientific Discovery and Research Infrastructure in the UAB Regional Biocontainment Laboratory (SEBLAB)
增强 UAB 区域生物防护实验室 (SEBLAB) 的科学发现和研究基础设施
  • 批准号:
    10626482
  • 财政年份:
    2021
  • 资助金额:
    $ 5.55万
  • 项目类别:
Upgrade and operational improvements to the SouthEastern Biosafety Laboratory, Alabama, Birmingham (SEBLAB)
阿拉巴马州伯明翰东南生物安全实验室 (SEBLAB) 的升级和运营改进
  • 批准号:
    10394580
  • 财政年份:
    2021
  • 资助金额:
    $ 5.55万
  • 项目类别:
The Pathogenesis of Aspergillus Keratitis
曲霉菌性角膜炎的发病机制
  • 批准号:
    7923157
  • 财政年份:
    2009
  • 资助金额:
    $ 5.55万
  • 项目类别:
The Pathogenesis of Aspergillus Keratitis
曲霉菌性角膜炎的发病机制
  • 批准号:
    8128621
  • 财政年份:
    2009
  • 资助金额:
    $ 5.55万
  • 项目类别:

相似海外基金

Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
  • 批准号:
    10727507
  • 财政年份:
    2023
  • 资助金额:
    $ 5.55万
  • 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
  • 批准号:
    9194162
  • 财政年份:
    2016
  • 资助金额:
    $ 5.55万
  • 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
  • 批准号:
    496858-2016
  • 财政年份:
    2016
  • 资助金额:
    $ 5.55万
  • 项目类别:
    University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
  • 批准号:
    9201955
  • 财政年份:
    2015
  • 资助金额:
    $ 5.55万
  • 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
  • 批准号:
    8251289
  • 财政年份:
    2014
  • 资助金额:
    $ 5.55万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8302750
  • 财政年份:
    2012
  • 资助金额:
    $ 5.55万
  • 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
  • 批准号:
    267940
  • 财政年份:
    2012
  • 资助金额:
    $ 5.55万
  • 项目类别:
    Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8403458
  • 财政年份:
    2012
  • 资助金额:
    $ 5.55万
  • 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8549297
  • 财政年份:
    2012
  • 资助金额:
    $ 5.55万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8472443
  • 财政年份:
    2012
  • 资助金额:
    $ 5.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了